Related Experiment Video
Updated: May 2, 2026

Cecal Ligation and Puncture-induced Sepsis as a Model To Study Autophagy in Mice
Published on: February 9, 2014
Tyrosine kinase 2 promotes sepsis-associated lethality by facilitating production of interleukin-27
Markus Bosmann1, Birgit Strobl2, Nadia Kichler2
1Center for Thrombosis and Hemostasis and Department of Hematology, Oncology and Pneumology, University Medical Center, Mainz, Germany; markus.bosmann@unimedizin-mainz.de.
Abstract:
The aim of this study was to test the hypothesis that gene expression and release of IL-27 may be modulated by Tyk2. Macrophages derived from the peritoneum or bone marrow of C57BL/10SnJ (WT) mice produced abundant amounts of IL-27(p28) following TLR4 activation by LPS. In contrast, production of IL-27(p28), but not EBI3, was reduced by ∼50% in TLR4-activated macrophages derived from mice with genetic deficiency of Tyk2 compared with WT macrophages. Frequencies of IL-27(p28)+F4/80+CD11b+ cells were lower in TLR4-activated macrophages derived from Tyk2-/- mice. Mechanistically, Tyk2-/- resulted in disruption of a type I IFN-dependent mechanism for production of IL-27(p28), which was induced by type I IFNs, and release of IL-27 was defective in macrophages from IFN-β-/- and IFNAR1-/- mice. In contrast, Tyk2 was not required to mediate the effects of IL-27 on target gene expression in CD4(+) T cells. In vivo, we observed that Tyk2-/- mice have improved survival following endotoxic shock or polymicrobial sepsis induced by CLP. Plasma levels of IL-27(p28) during endotoxic shock or polymicrobial sepsis were markedly reduced in Tyk2-/- mice compared with WT mice. Disruption of IL-27 signaling using IL-27RA-/- mice was protective against sepsis-associated mortality. These data suggest that Tyk2 may mediate adverse outcomes of SIRS by promoting the production of IL-27. In conclusion, this report identifies Tyk2 as a prerequisite factor in the molecular networks that are involved in generation of IL-27.
Insights
The tyrosine kinase 2 (Tyk2) enzyme promotes the production of Interleukin-27 (IL-27), a cytokine implicated in severe systemic inflammation. Inhibiting Tyk2 may offer a therapeutic strategy for sepsis and endotoxic shock by reducing IL-27 levels.
Area of Science:
- Immunology
- Molecular Biology
- Inflammation Research
Background:
- Interleukin-27 (IL-27) is a key cytokine in immune responses.
- Tyk2 (tyrosine kinase 2) is an enzyme involved in cytokine signaling.
- The precise role of Tyk2 in IL-27 production and its impact on systemic inflammation is not fully understood.
Purpose of the Study:
- To investigate the role of Tyk2 in the gene expression and release of IL-27.
- To determine if Tyk2 modulates IL-27 production in macrophages.
- To assess the in vivo relevance of Tyk2-mediated IL-27 production in models of sepsis and endotoxic shock.
Main Methods:
- Utilized wild-type (WT) and Tyk2-deficient (Tyk2-/-) mouse macrophages (peritoneal and bone marrow-derived).
- Stimulated macrophages with lipopolysaccharide (LPS) to activate Toll-like receptor 4 (TLR4).
- Measured IL-27(p28) and EBI3 production via quantitative assays and flow cytometry.
- Investigated the role of type I interferons (IFN) and IL-27 receptor alpha (IL-27RA) in vivo.
- Assessed survival rates in Tyk2-/- and IL-27RA-/- mice subjected to endotoxic shock and cecal ligation and puncture (CLP) sepsis models.
Main Results:
- Tyk2 deficiency significantly reduced IL-27(p28) production (by ~50%) in TLR4-activated macrophages, while EBI3 production remained unaffected.
- Tyk2 deficiency impaired a type I IFN-dependent mechanism for IL-27(p28) production.
- Tyk2 was not required for IL-27's effects on CD4+ T cells.
- Tyk2-/- mice exhibited improved survival rates in models of endotoxic shock and polymicrobial sepsis.
- Plasma IL-27(p28) levels were markedly reduced in Tyk2-/- mice during sepsis.
- Disruption of IL-27 signaling via IL-27RA deficiency was protective against sepsis-associated mortality.
Conclusions:
- Tyk2 is a critical prerequisite factor for IL-27(p28) generation, particularly in response to TLR4 activation.
- Tyk2-mediated IL-27 production contributes to adverse outcomes in systemic inflammatory responses such as sepsis.
- Targeting Tyk2 may represent a potential therapeutic strategy to mitigate inflammatory conditions driven by excessive IL-27 production.
Related Concept Videos
The JAK-STAT Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway
Acute Pancreatitis II: Pathophysiology
Acute Inflammation II: Local and Systemic Effects
MAPK Signaling Cascades
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

